Why is Tatva Chintan Pharma Chem Ltd ?
- The company has declared positive results for the last 4 consecutive quarters
- PBDIT(Q) Highest at Rs 32.30 cr.
- PBT LESS OI(Q) At Rs 19.65 cr has Grown at 47.0% (vs previous 4Q average)
- PAT(Q) At Rs 16.98 cr has Grown at 61.5% (vs previous 4Q average)
- The stock has generated a return of 69.95% in the last 1 year, much higher than market (BSE500) returns of 5.50%
How much should you buy?
- Overall Portfolio exposure to Tatva Chintan should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Tatva Chintan for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at Rs 32.30 cr.
At Rs 19.65 cr has Grown at 47.0% (vs previous 4Q average
At Rs 16.98 cr has Grown at 61.5% (vs previous 4Q average
At Rs 167.06 cr has Grown at 32.1% (vs previous 4Q average
Highest at Rs 6.83
Lowest at Rs 8.79 cr
Lowest at 4.25 times
Here's what is working for Tatva Chintan
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
PBT less Other Income (Rs Cr)
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Net Sales (Rs Cr)
PAT (Rs Cr)
EPS (Rs)
Here's what is not working for Tatva Chintan
Cash and Cash Equivalents
Debtors Turnover Ratio
Non Operating Income






